OGX-011
R04-0092
Phase 2 mab completed
Quick answer
OGX-011 for Prostate Cancer is a Phase 2 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Prostate Cancer
- Phase
- Phase 2
- Modality
- mab
- Status
- completed